Financial results - ANGIOLIFE DR. PUSCASU SRL

Financial Summary - Angiolife Dr. Puscasu Srl
Unique identification code: 36628007
Registration number: J35/2796/2016
Nace: 8622
Sales - Ron
48.931
Net Profit - Ron
11.188
Employees
1
Open Account
Company Angiolife Dr. Puscasu Srl with Fiscal Code 36628007 recorded a turnover of 2024 of 48.931, with a net profit of 11.188 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Angiolife Dr. Puscasu Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 1.136 5.837 8.264 9.627 9.116 20.146 32.305 41.824 48.931
Total Income - EUR - 1.136 5.837 8.264 11.491 9.116 20.595 32.795 42.315 49.418
Total Expenses - EUR - 209 512 2.402 6.539 9.168 13.376 23.382 16.504 36.982
Gross Profit/Loss - EUR - 927 5.325 5.861 4.952 -51 7.219 9.414 25.810 12.436
Net Profit/Loss - EUR - 892 5.150 5.613 4.663 -312 6.627 8.712 25.455 11.188
Employees - 0 0 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 17.6%, from 41.824 euro in the year 2023, to 48.931 euro in 2024. The Net Profit decreased by -14.125 euro, from 25.455 euro in 2023, to 11.188 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Angiolife Dr. Puscasu Srl

Rating financiar

Financial Rating -
ANGIOLIFE DR. PUSCASU SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Angiolife Dr. Puscasu Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Angiolife Dr. Puscasu Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Angiolife Dr. Puscasu Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Angiolife Dr. Puscasu Srl - CUI 36628007

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 0 0 0 1.864 2.022 2.918 3.617 6.918 38.495
Current Assets - 971 6.126 11.634 14.261 15.433 20.526 28.487 49.888 28.887
Inventories - 0 0 0 0 0 0 849 0 0
Receivables - 273 301 289 221 0 255 587 42.454 17.437
Cash - 698 5.825 11.345 14.039 15.433 20.272 27.050 7.434 11.450
Shareholders Funds - 937 6.071 11.573 16.012 15.397 21.682 30.461 55.824 66.699
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 34 54 60 112 57 255 621 453 643
Income in Advance - 0 0 0 0 2.001 1.508 1.022 530 40
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 28.887 euro in 2024 which includes Inventories of 0 euro, Receivables of 17.437 euro and cash availability of 11.450 euro.
The company's Equity was valued at 66.699 euro, while total Liabilities amounted to 643 euro. Equity increased by 11.188 euro, from 55.824 euro in 2023, to 66.699 in 2024. The Debt Ratio was 1.0% in the year 2024.

Risk Reports Prices

Reviews - Angiolife Dr. Puscasu Srl

Comments - Angiolife Dr. Puscasu Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.